复杂干预的健康技术评估方法:一个范围审查
Abdolvahab Baghbanian1, Drew Carter1, Tracy Merlin1
1Adelaide Health Technology Assessment, School of Public Health, University of Adelaide, Adelaide, South Australia, Australia.
PloS one
|March 14, 2025
概括
这一范围审查显示,复杂干预的健康技术评估 (HTA) 越来越多地包含了传统领域之外的更广泛的上下文和实施因素. 理论指导和实际应用之间存在差异,需要进一步研究以达成对指标的共识.
科学领域:
- 医疗技术评估 (HTA) 是指对医疗技术进行评估.
- 复杂的干预 复杂的干预
- 基于证据的政策制定.
背景情况:
- 传统的卫生技术评估 (HTA) 方法在复杂的卫生干预方面面临挑战.
- 本综述综合了针对复杂干预的HTA的国际方法.
- 探讨的关键领域包括评估标准,证据类型和受欢迎的价值领域.
研究的目的:
- 对复杂干预的HTA进行国际方法的整理和综合.
- 确定复杂干预的HTA中使用的评估标准,证据类型和价值领域.
- 分析复杂干预的HTA方法的趋势和差异.
主要方法:
- 按照JBI指导方针和Arksey和O'Malley的框架进行系统的范围审查.
- 搜索了七个电子数据库,灰色文献和HTA期刊 (2000年1月至2023年12月).
- 使用人口,概念和上下文 (PCC) 框架用于文献选择和叙事合成.
主要成果:
- 确定了来自12个国家的35份记录,分组为方法/概念 (19) 和实践HTA报告 (16).
- 三种HTA方法出现了:整合性,顺序性和并发性.
- 成本效益,临床有效性和组织方面的因素占主导地位,越来越重视患者/社会因素和独特的领域,如实施和现实世界的数据.
结论:
- 显而易见的是,复杂干预的HTA中包含了更广泛的上下文和实施因素的趋势.
- 在HTA理论指导和实际应用之间仍然存在差异.
- 未来的研究应该探索这些转变的影响,以建立对指标的共识,并优化复杂干预的HTA.
相关概念视频
01:29Nursing Assessment
9.8K
The two sources for collecting information are primary and secondary. After gathering information, interpretation and validation help to complete the data. The purpose of assessment is to establish data with the initial information, to interpret data about the patient's perceived needs and health problems, and to respond to these problems identified.
The nurse collects all aspects of the patient's health in the initial assessment, establishing priorities for ongoing focused assessments...
The nurse collects all aspects of the patient's health in the initial assessment, establishing priorities for ongoing focused assessments...
9.8K
01:29Nursing Interventions II: Selecting and Classifying the Nursing Interventions
3.7K
Creating and executing a nursing diagnosis helps nurses plan care and guide patient, family, and community interventions. They are developed based on a patient's physical evaluation and support measuring the outcomes. It is not recommended to select random interventions throughout the planning process. Instead, consider the following six essential factors when choosing interventions:
3.7K
01:29Documentation in Long-Term and Home Healthcare Setting
1.7K
Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
Long-Term Care Facilities
1.7K
01:30Health Information Technology and Healthcare Information System
3.6K
Health Information Technology (HIT)
Health Information Technology, commonly called HIT, integrates advanced information systems and technology in healthcare settings. Its primary functions include:
Health Information Technology, commonly called HIT, integrates advanced information systems and technology in healthcare settings. Its primary functions include:
3.6K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
533
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
533
01:12Hazard Ratio
705
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
705